Delivery Order SPE2DB22D2206-SPE2DB25FJS91
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,323.06 on August 13, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This delivery order...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $3,228.25 delivery order on August 29, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pens with a completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning the award was competitively issued. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a ceiling value of $13,886.60 under a firm fixed-price contract. The order, which represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA, will be fulfilled from the vendor's Conshohocken, Pennsylvania location and is scheduled for completion by August 29, 2025. This delivery order was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a firm fixed price ceiling value of $6,097.91. This non-competitive delivery order is expected to be completed by August 26, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $8,703.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,720.90 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injections on September 2, 2025, with a completion date of September 3, 2025. This non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order, indicating it is issued under a larger indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors with a completion date of July 30, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a $10,019.57 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens (0.5 ml units). This competitively awarded, firm fixed-price contract will be completed by July 21, 2025, with performance taking place at the vendor's Corporate Office in Conshohocken, Pennsylvania. The award represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $5,420.32 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This firm fixed-price contract, which is a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, represents a competitively awarded procurement with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJS91Delivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $16,728.19 on September 2, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen (0.5 mL) to be delivered to Conshohocken, Pennsylvania. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. The contract is classified as a child award, indicating it is issued against a parent indefinite delivery contract (IDC) that provides the overarching terms and conditions for pharmaceutical supply. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply an extensive range of medications and medical supplies to military healthcare programs worldwide, including support for the Defense Health Agency and U.S. Coast Guard. Mounjaro, a diabetes medication, is among the specialized pharmaceutical products within the company's federal contract portfolio, reflecting AmerisourceBergen's role as a critical vendor for military medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 9/2/25 |